BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16024782)

  • 1. hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation.
    Lynch M; Chen L; Ravitz MJ; Mehtani S; Korenblat K; Pazin MJ; Schmidt EV
    Mol Cell Biol; 2005 Aug; 25(15):6436-53. PubMed ID: 16024782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel regulatory factors interacting with the promoter of the gene encoding the mRNA cap binding protein (eIF4E) and their function in growth regulation.
    Johnston KA; Polymenis M; Wang S; Branda J; Schmidt EV
    Mol Cell Biol; 1998 Oct; 18(10):5621-33. PubMed ID: 9742079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc.
    Jones RM; Branda J; Johnston KA; Polymenis M; Gadd M; Rustgi A; Callanan L; Schmidt EV
    Mol Cell Biol; 1996 Sep; 16(9):4754-64. PubMed ID: 8756633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
    Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
    RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of the rat eIF4E gene in cardiac muscle cells: the role of specific elements in the promoter region.
    Makhlouf AA; Namboodiri AM; McDermott PJ
    Gene; 2001 Apr; 267(1):1-12. PubMed ID: 11311550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.
    Topisirovic I; Ruiz-Gutierrez M; Borden KL
    Cancer Res; 2004 Dec; 64(23):8639-42. PubMed ID: 15574771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous nuclear ribonucleoprotein K is a transcription factor.
    Michelotti EF; Michelotti GA; Aronsohn AI; Levens D
    Mol Cell Biol; 1996 May; 16(5):2350-60. PubMed ID: 8628302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.
    Topisirovic I; Guzman ML; McConnell MJ; Licht JD; Culjkovic B; Neering SJ; Jordan CT; Borden KL
    Mol Cell Biol; 2003 Dec; 23(24):8992-9002. PubMed ID: 14645512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of translation and miRNA-dependent repression by a novel poly(A) binding protein, hnRNP-Q.
    Svitkin YV; Yanagiya A; Karetnikov AE; Alain T; Fabian MR; Khoutorsky A; Perreault S; Topisirovic I; Sonenberg N
    PLoS Biol; 2013; 11(5):e1001564. PubMed ID: 23700384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of heterogeneous nuclear ribonucleoprotein K gene expression.
    He L; Xue X; Wang Z; Hou E; Liu Y; Liang M; Zhang Y; Tian Z
    Biochimie; 2015 Feb; 109():27-35. PubMed ID: 25497182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium arsenite-induced inhibition of eukaryotic translation initiation factor 4E (eIF4E) results in cytotoxicity and cell death.
    Othumpangat S; Kashon M; Joseph P
    Mol Cell Biochem; 2005 Nov; 279(1-2):123-31. PubMed ID: 16283521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma.
    Li S; Fu J; Lu C; Mapara MY; Raza S; Hengst U; Lentzsch S
    Mol Cancer Ther; 2016 Apr; 15(4):711-9. PubMed ID: 26939700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. eIF4E is a central node of an RNA regulon that governs cellular proliferation.
    Culjkovic B; Topisirovic I; Skrabanek L; Ruiz-Gutierrez M; Borden KL
    J Cell Biol; 2006 Nov; 175(3):415-26. PubMed ID: 17074885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity.
    Feoktistova K; Tuvshintogs E; Do A; Fraser CS
    Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13339-44. PubMed ID: 23901100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.
    Li Y; Yue P; Deng X; Ueda T; Fukunaga R; Khuri FR; Sun SY
    Neoplasia; 2010 Oct; 12(10):848-55. PubMed ID: 20927323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational homeostasis via the mRNA cap-binding protein, eIF4E.
    Yanagiya A; Suyama E; Adachi H; Svitkin YV; Aza-Blanc P; Imataka H; Mikami S; Martineau Y; Ronai ZA; Sonenberg N
    Mol Cell; 2012 Jun; 46(6):847-58. PubMed ID: 22578813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous nuclear ribonucleoprotein K represses transcription from a cytosine/thymidine-rich element in the osteocalcin promoter.
    Stains JP; Lecanda F; Towler DA; Civitelli R
    Biochem J; 2005 Jan; 385(Pt 2):613-23. PubMed ID: 15361071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation.
    Villalonga P; Fernández de Mattos S; Ridley AJ
    J Biol Chem; 2009 Dec; 284(51):35287-96. PubMed ID: 19850923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LMP1 stimulates the transcription of eIF4E to promote the proliferation, migration and invasion of human nasopharyngeal carcinoma.
    Zhao Y; Pang TY; Wang Y; Wang S; Kang HX; Ding WB; Yong WW; Bie YH; Cheng XG; Zeng C; Yao YH; Li Q; Hu XR
    FEBS J; 2014 Jul; 281(13):3004-18. PubMed ID: 24814906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of mRNA translation in oncogenesis: the role of eIF4E.
    Montanaro L; Pandolfi PP
    Cell Cycle; 2004 Nov; 3(11):1387-9. PubMed ID: 15492504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.